METHOD FOR PREVENTING INFLAMMATORY DISEASES OF FEMALE GENITAL ORGANS

FIELD: medicine, obstetrics, gynecology. ^ SUBSTANCE: the present innovation deals with hygienic products applied for preventing inflammatory diseases of genital organs and could be used as antibacterial filler for female hygienic panty shield and/or tampon for daily usage. The suggested innovation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STEPANOVA ANASTASIJA IVANOVNA, BARKOVA ANNA JUR'EVNA, FADEEVA ELENA KONSTANTINOVNA, BOL'SHAKOV IGOR' NIKOLAEVICH, POLJANSKAJA RIMMA TIMOFEEVNA, PER'JANOVA OL'GA VLADIMIROVNA, RUPPEL' NADEZHDA IVANOVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, obstetrics, gynecology. ^ SUBSTANCE: the present innovation deals with hygienic products applied for preventing inflammatory diseases of genital organs and could be used as antibacterial filler for female hygienic panty shield and/or tampon for daily usage. The suggested innovation has the tendency to solve the problem in developing efficient filler for female hygienic panty shield and/or tampon for daily usage to prevent inflammatory diseases of genital organs being of the following advantages: absolute intoxicity, prophylactic action in case of potential development of inflammatory process in female genital tract, antibacterial effect, selective action upon microflora of female genital organs at keeping the number of viable useful lactobacilli, steady action upon mucosa and skin of genital organs due to viscosity and high fluidity of gel composition, form-resistance of gel composition along with its transparency and absence of fragrance, no formation of antibioticoresistant strains of microorganisms at daily applications of panty shields or tampons. The purpose mentioned should be achieved due to the fact that the filler in the composition of panty shield or tampon contains about 0.5-1%-chitosan hydrochloride aqueous solution for medicinal indication ("M" mark) at molecular weight ranged 300-700 kDa, at degree of deacetylation being 89-98% at the following ratio of components/1000 ml composition: dry chitosan hydrochloride 5-10 g, distilled water - the rest. For normalizing vaginal biocenosis 10 applications will be sufficient. ^ EFFECT: higher efficiency of prophylaxis. ^ 1 ex, 1 tbl